XML 27 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company's assets that are measured at fair value on a recurring basis consist of the following:
 
 
 
Fair Value Measurements at Reporting Date Using
As of June 30, 2019
Fair Value
 
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
Available-for-sale debt securities:
 
 
 
 
 
Corporate bonds
$
3,794.6

 

 
$
3,794.6

U.S. government and government agency obligations
119.4

 

 
119.4

Sovereign bonds
27.3

 

 
27.3

Commercial paper
99.7

 

 
99.7

Certificates of deposit
53.8

 

 
53.8

Equity securities (unrestricted)
67.0

 
$
67.0

 

Equity securities (restricted)
347.0

 
62.2

 
284.8

 
$
4,508.8

 
$
129.2

 
$
4,379.6

 
 
 
 
 
 
As of December 31, 2018
 
 
 
 
 
Available-for-sale debt securities:
 
 
 
 
 
Corporate bonds
$
2,718.4

 

 
$
2,718.4

U.S. government and government agency obligations
109.4

 

 
109.4

Sovereign bonds
7.6

 

 
7.6

Commercial paper
113.8

 

 
113.8

Certificates of deposit
60.0

 

 
60.0

Equity securities (unrestricted)
43.6

 
$
43.6

 

Equity securities (restricted)
44.4

 

 
44.4

 
$
3,097.2

 
$
43.6

 
$
3,053.6


Marketable securities included in Level 2 are valued using quoted market prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, or model-based valuations in which significant inputs used are observable. The Company considers market liquidity in determining the fair value for these securities.
The Company held certain restricted equity securities as of June 30, 2019, including its investment in Alnylam (see Note 3), which are subject to transfer restrictions until 2023.
During the three and six months ended June 30, 2019, we recorded $116.9 million and $74.1 million, respectively, of net unrealized losses on equity securities in Other income (expense), net. During the three and six months ended June 30, 2018, we recorded $16.5 million and $25.9 million, respectively, of net unrealized gains on equity securities in Other income (expense), net.
As of June 30, 2019 and December 31, 2018, the Company had $45.5 million in equity investments that do not have a readily determinable fair value. These investments are recorded within Other noncurrent assets.